These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6482431)

  • 1. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
    Singh RK; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Aug; 21(2):205-8. PubMed ID: 6482431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
    Ruh MF; Brzyski RG; Strange L; Ruh TS
    Endocrinology; 1983 Jun; 112(6):2203-5. PubMed ID: 6851947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
    Jasper TW; Ruh MF; Ruh TS
    J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]estradiol- and [3H]H1285-receptor complexes to rabbit uterine chromatin.
    Singh RK; Ruh MF; Ruh TS
    Biochim Biophys Acta; 1984 Jul; 800(1):33-40. PubMed ID: 6743683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK; Ruh MF; Butler WB; Ruh TS
    Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
    Turner JW; Ruh MF; Ward DT; Ruh TS
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):197-203. PubMed ID: 2004041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the form of the salt-transformed estrogen receptor when bound by estrogen versus antiestrogen.
    Ruh MF; Turner JW; Paulson CM; Ruh TS
    J Steroid Biochem; 1990 Aug; 36(6):509-16. PubMed ID: 2214766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the radiolabelled high-affinity anti-oestrogen [3H]H1285 with the cytoplasmic oestrogen receptor.
    Keene JL; Sweet F; Ruh MF; Ruh TS
    Biochem J; 1984 Feb; 217(3):819-26. PubMed ID: 6712598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molybdate interaction with the estrogen receptor: effects on estradiol binding and receptor activation.
    Mauck LA; Day RN; Notides AC
    Biochemistry; 1982 Apr; 21(8):1788-93. PubMed ID: 7082647
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
    Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
    Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calf uterine estradiol receptor. Effects of molybdate on salt-induced transformation process and characterization of a nontransformed receptor state.
    Redeuilh G; Secco C; Baulieu EE; Richard-Foy H
    J Biol Chem; 1981 Nov; 256(22):11496-502. PubMed ID: 7298613
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of two forms of molybdate-stabilized estrogen receptor.
    Ruh MF; Ruh TS
    Endocrinology; 1984 Oct; 115(4):1341-9. PubMed ID: 6479095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sodium molybdate on cytosolic estrogen receptor.
    Moncharmont B; Parikh I; Puca GA; Cuatrecasas P
    J Steroid Biochem; 1982 Mar; 16(3):361-8. PubMed ID: 7087464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of non-activated and activated estrogen- and antiestrogen-receptor complexes by high performance ion exchange chromatography.
    Myatt L; Wittliff JL
    J Steroid Biochem; 1986 May; 24(5):1041-8. PubMed ID: 3724142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of uterine estrogen receptor transformation by sodium molybdate.
    Shyamala G; Leonard L
    J Biol Chem; 1980 Jul; 255(13):6028-31. PubMed ID: 7391003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.